ArticleTargeted oncology2024

Durvalumab Plus Gemcitabine and Cisplatin in Patients with Advanced Biliary Tract Cancer: An Exploratory Analysis of Real-World Data.

Alexander Olkus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.